CLINICAL_TRIALS trial_result · 2014-04-01

Clinical Trial Update: A Phase 3 Study to Investigate the Safety and Efficacy of PA21, a Phosphate Binder, in Dialysis Patients [Phase 3]

Phase 3 trial update for PA21, a phosphate binder, in dialysis patients with chronic kidney disease; results were posted on 2014-04-01.

Upgrade for the full analysis, importance score, and drug timeline.

Sponsor: Vifor Pharma | Conditions: Chronic Kidney Disease Requiring Chronic Dialysis | Phase 3 | Status: COMPLETED | Results posted: 2014-04-01